Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
New targets and therapeutic approaches for endocrine malignancies
Pharmacology & Therapeutics, 06/15/09
Fassnacht M et al. - This review covers these recent molecular and clinical advances which most likely will dramatically alter the treatment of endocrine malignancies within the coming decade.
Related Articles
Improving prediction of malignancy of cytologically indeterminate thyroid nodules
British Journal of Surgery, 11/17/09
Relevance Score: 65%
Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies
Diagnostic Cytopathology, 10/14/09
Relevance Score: 65%
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Relevance Score: 64%
Solitary Lung Metastasis Diagnosed 30 Years After Surgery for Thyroid Cancer
Annals of Thoracic Surgery, 11/25/09
Relevance Score: 64%
Sexual Ramifications of Medical Illness
Clinical Obstetrics and Gynecology, 11/09/09
Relevance Score: 64%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


